BerGenBio ASA reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was NOK 48.84 million compared to NOK 84.07 million a year ago. Basic loss per share from continuing operations was NOK 15 compared to NOK 95 a year ago.
For the six months, net loss was NOK 120.83 million compared to NOK 165.14 million a year ago. Basic loss per share from continuing operations was NOK 57 compared to NOK 186 a year ago.